Who clears biological E’s nopv2 production expansion, boosting global polio fight
Hyderabad, Feb.12 (RAHNUMA): Hyderabad-based Biological E. Limited has secured Phase II Pre-Qualification (PQ) from the World Health Organization (WHO) for its Novel Oral Polio Vaccine type 2 (nOPV2), enabling full end-to-end manufacturing at a single integrated facility. The approval covers both drug substance and drug product manufacturing, expanding on the Phase I PQ granted in […]
